UBS Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.6M | Buy |
2,944,888
+949,281
| +48% | +$6.5M | ﹤0.01% | 2458 |
|
|
2025
Q4 | $3.95M | Buy |
1,995,607
+315,025
| +19% | +$714K | ﹤0.01% | 4262 |
|
|
2025
Q3 | $4.13M | Buy |
1,680,582
+489,935
| +41% | +$1.26M | ﹤0.01% | 4238 |
|
|
2025
Q2 | $3.14M | Sell |
1,190,647
-247,769
| -17% | -$666K | ﹤0.01% | 4348 |
|
|
2025
Q1 | $4.33M | Sell |
1,438,416
-149,273
| -9% | -$452K | ﹤0.01% | 3929 |
|
|
2024
Q4 | $4.06M | Buy |
1,587,689
+1,181,256
| +291% | +$4.92M | ﹤0.01% | 4057 |
|
|
2024
Q3 | $1.51M | Sell |
406,433
-51,822
| -11% | -$240K | ﹤0.01% | 4268 |
|
|
2024
Q2 | $2.9M | Sell |
458,255
-467,234
| -50% | -$3.08M | ﹤0.01% | 3384 |
|
|
2024
Q1 | $4.97M | Buy |
925,489
+882,777
| +2,067% | +$4M | ﹤0.01% | 2982 |
|
|
2023
Q4 | $214K | Buy |
42,712
+2,930
| +7% | +$9.19K | ﹤0.01% | 5740 |
|
|
2023
Q3 | $67.2K | Buy |
39,782
+70
| +0.2% | +$141 | ﹤0.01% | 6095 |
|
|
2023
Q2 | $110K | Sell |
39,712
-74,666
| -65% | -$211K | ﹤0.01% | 5926 |
|
|
2023
Q1 | $208K | Sell |
114,378
-254,225
| -69% | -$790K | ﹤0.01% | 5359 |
|
|
2022
Q4 | $1.87M | Buy |
368,603
+252,685
| +218% | +$1.39M | ﹤0.01% | 3454 |
|
|
2022
Q3 | $576K | Buy |
115,918
+65,845
| +131% | +$300K | ﹤0.01% | 4202 |
|
|
2022
Q2 | $186K | Sell |
50,073
-122,957
| -71% | -$494K | ﹤0.01% | 4984 |
|
|
2022
Q1 | $971K | Sell |
173,030
-181,957
| -51% | -$1.12M | ﹤0.01% | 4128 |
|
|
2021
Q4 | $2.16M | Buy |
354,987
+76,288
| +27% | +$573K | ﹤0.01% | 3664 |
|
|
2021
Q3 | $2.71M | Buy |
278,699
+251,520
| +925% | +$2.77M | ﹤0.01% | 3305 |
|
|
2021
Q2 | $388K | Sell |
27,179
-28,835
| -51% | -$476K | ﹤0.01% | 4906 |
|
|
2021
Q1 | $1.33M | Buy |
56,014
+50,858
| +986% | +$1.32M | ﹤0.01% | 3958 |
|
|
2020
Q4 | $69K | Sell |
5,156
-5,259
| -50% | -$50.6K | ﹤0.01% | 5930 |
|
|
2020
Q3 | $72K | Sell |
10,415
-5,297
| -34% | -$52.8K | ﹤0.01% | 5397 |
|
|
2020
Q2 | $193K | Buy |
15,712
+10,162
| +183% | +$57.4K | ﹤0.01% | 4819 |
|
|
2020
Q1 | $16K | Sell |
5,550
-4,251
| -43% | -$21.3K | ﹤0.01% | 6632 |
|
|
2019
Q4 | $37K | Sell |
9,801
-4,253
| -30% | -$7.24K | ﹤0.01% | 6526 |
|
|
2019
Q3 | $17K | Buy |
14,054
+6,633
| +89% | +$8.23K | ﹤0.01% | 6829 |
|
|
2019
Q2 | $8K | Sell |
7,421
-4,814
| -39% | -$5.55K | ﹤0.01% | 7185 |
|
|
2019
Q1 | $19K | Sell |
12,235
-11,769
| -49% | -$14.8K | ﹤0.01% | 6346 |
|
|
2018
Q4 | $28K | Buy |
24,004
+17,004
| +243% | +$38.9K | ﹤0.01% | 6528 |
|
|
2018
Q3 | $26K | Sell |
7,000
-41,523
| -86% | -$131K | ﹤0.01% | 6633 |
|
|
2018
Q2 | $149K | Buy |
48,523
+41,523
| +593% | +$154K | ﹤0.01% | 5154 |
|
|
2018
Q1 | $27K | Sell |
7,000
-5,564
| -44% | -$24.4K | ﹤0.01% | 6184 |
|
|
2017
Q4 | $56K | Buy |
12,564
+1,187
| +10% | +$5.62K | ﹤0.01% | 5746 |
|
|
2017
Q3 | $62K | Buy |
11,377
+2,138
| +23% | +$13.2K | ﹤0.01% | 5640 |
|
|
2017
Q2 | $70K | Buy |
9,239
+1,689
| +22% | +$7.3K | ﹤0.01% | 5413 |
|
|
2017
Q1 | $27K | Buy |
7,550
+5,050
| +202% | +$25K | ﹤0.01% | 5934 |
|
|
2016
Q4 | $14K | Sell |
2,500
-370
| -13% | -$2.47K | ﹤0.01% | 6723 |
|
|
2016
Q3 | $23K | Buy |
2,870
+670
| +30% | +$5.01K | ﹤0.01% | 6189 |
|
|
2016
Q2 | $13K | Sell |
2,200
-700
| -24% | -$5.43K | ﹤0.01% | 6617 |
|
|
2016
Q1 | $24K | Buy |
2,900
+850
| +41% | +$8.01K | ﹤0.01% | 6062 |
|
|
2015
Q4 | $36K | Buy |
2,050
+50
| +3% | +$742 | ﹤0.01% | 6142 |
|
|
2015
Q3 | $23K | Buy |
+2,000
| New | +$43.6K | ﹤0.01% | 6577 |
|
Other funds holding IBRX
VPM
VCM
HF
WP